Wu X - Search Results

1

PEA3 activates VEGF transcription in T47D and SKBR3 breast cancer cells.

Hua D, Chen B, Bai M, Yu H, Wu X, Jin W. Hua D, et al. Among authors: wu x. Acta Biochim Biophys Sin (Shanghai). 2009 Jan;41(1):63-8. doi: 10.1093/abbs/gmn007. Acta Biochim Biophys Sin (Shanghai). 2009. PMID: 19129951 Free article.

2

Three vascular endothelial growth factor polymorphisms (-460C>T, -2578C>A, 1612G>A) with cancer risk: a meta-analysis based on 30 case-control studies.

Hong TT, Cai DY, Wu XH, Hua D. Hong TT, et al. Cancer Invest. 2011 Aug;29(7):472-7. doi: 10.3109/07357907.2011.597811. Cancer Invest. 2011. PMID: 21740084

3

Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.

Hong TT, Zhang RX, Wu XH, Hua D. Hong TT, et al. Mol Biol Rep. 2012 May;39(5):5283-9. doi: 10.1007/s11033-011-1326-9. Epub 2011 Dec 14. Mol Biol Rep. 2012. PMID: 22167330

4

Cullin-1 promotes cell proliferation in human breast cancer and is related to diabetes.

Zhou YH, Xia J, Xu WH, Zhu X, Wu XH, Hua D, Xing C. Zhou YH, et al. Among authors: wu xh. Int J Biol Markers. 2016 Dec 23;31(4):e375-e381. doi: 10.5301/jbm.5000215. Int J Biol Markers. 2016. PMID: 27312587 Free article.

5

Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.

Hong T, Liu A, Cai D, Zhang Y, Hua D, Hang X, Wu X. Hong T, et al. Among authors: wu x. Cancer Invest. 2013 May;31(4):279-85. doi: 10.3109/07357907.2013.789898. Cancer Invest. 2013. PMID: 23627410

6

CD61+ and CAF+ were found to be good prognosis factors for invasive breast cancer patients.

Cai D, Wu X, Hong T, Mao Y, Ge X, Hua D. Cai D, et al. Among authors: wu x. Pathol Res Pract. 2017 Oct;213(10):1296-1301. doi: 10.1016/j.prp.2017.06.016. Epub 2017 Jun 30. Pathol Res Pract. 2017. PMID: 28935175

7

[Efficacy and safety of docetaxol, pemetrexed and EGFR-TKIs as second-line treatment for patients with advanced non-small-cell lung cancer].

Zhang RX, Cai DY, Wu XH, Hua D. Zhang RX, et al. Zhonghua Zhong Liu Za Zhi. 2012 Nov;34(11):869-72. doi: 10.3760/cma.j.issn.0253-3766.2012.11.016. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 23291140 Chinese.

8

Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cells.

Du F, Wu X, Liu Y, Wang T, Qi X, Mao Y, Jiang L, Zhu Y, Chen Y, Zhu R, Han X, Jin J, Ma X, Hua D. Du F, et al. Among authors: wu x. Oncol Rep. 2013 Sep;30(3):1113-8. doi: 10.3892/or.2013.2567. Epub 2013 Jun 26. Oncol Rep. 2013. PMID: 23807572

9

[Comparison of the efficacy of second line EGFR TKIs followed by third line pemetrexed or the reverse sequence in the treatment of advanced lung adenocarcinoma].

Zhang RX, Cai DY, Hong TT, Wu XH, Hua D. Zhang RX, et al. Zhonghua Zhong Liu Za Zhi. 2012 Feb;34(2):147-51. doi: 10.3760/cma.j.issn.0253-3766.2012.02.015. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22780936 Chinese.

10

Preoperative serum lipid profile and outcome in nonmetastatic colorectal cancer.

Hong TT, Shen D, Chen XP, Wu XH, Hua D. Hong TT, et al. Chronic Dis Transl Med. 2016 Dec 22;2(4):241-249. doi: 10.1016/j.cdtm.2016.11.015. eCollection 2016 Dec. Chronic Dis Transl Med. 2016. PMID: 29063049 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,483 results

Search Page

Filters